Starting Monday, thousands in England can access weight-loss medication Mounjaro through their GP, marking a significant change in NHS policy. About 220,000 individuals facing severe obesity and related health issues such as diabetes and heart disease will be eligible for the treatment over three years. GPs are concerned about managing the increased workload and training required for effective patient care. The rollout aims to support patients needing assistance in weight loss, emphasizing the importance of addressing healthcare delivery challenges to ensure safety and efficacy.
‘While we recognize the potential benefits of weight-loss drugs, we know many GPs are concerned about the implications of the rollout of weight-loss drugs into general practice.’
‘This must be factored into this rollout in order to guarantee it can be delivered safely.’
Collection
[
|
...
]